BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs4950928
,
BRCA1
,
Response to oxidative stress
,
Breast Cancer
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
human malignant cells
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
GSK cancer cell line transcript profiling
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Cigarette smoke extracts induce overexpression of the proto-oncogenic gene interleukin-13 receptor α…
The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects.
Transfer of malignant trait to immortalized human cells following exposure to human cancer serum.
Seborrheic keratosis with bowenoid transformation: the immunohistochemical features and its associat…
Fatty Acid-Mediated Stromal Reprogramming of Pancreatic Stellate Cells Induces Inflammation and Fibr…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Humanized CAR-T Therapy for Treatment of B Cell Malignancy
A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies
A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies
A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignan…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ